Sign in
4

Changes in Ownership

Mineralys Therapeutics, Inc. Filed Acc 0001933414-23-000022

Options or other derivatives

  • Chief Medical Officer acquired 20,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Rodman David Malcom · Chief Medical Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-03-17 Grant or award : show line 1 in the form Stock Option +20,000 20,000 D
Loading xslF345X04/wf-form4_167943889214123.xml…